Rani Therapeutics stock soars after inking $1 billion potential deal with Chugai
PositiveFinancial Markets

Rani Therapeutics has seen its stock price soar following a significant potential deal worth $1 billion with Chugai Pharmaceutical. This partnership could pave the way for innovative developments in drug delivery systems, making it a pivotal moment for Rani as they aim to enhance their market presence and product offerings. Investors are optimistic about the future, as this collaboration may lead to groundbreaking advancements in the pharmaceutical industry.
— Curated by the World Pulse Now AI Editorial System